carbidopa and Degenerative Diseases, Central Nervous System

carbidopa has been researched along with Degenerative Diseases, Central Nervous System in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's1 (14.29)24.3611
2020's5 (71.43)2.80

Authors

AuthorsStudies
Cubo, E; Miranda, J1
Alobaidi, A; Bao, Y; Chaudhuri, KR; Jalundhwala, YJ; Jones, G; Kandukuri, PL; Madin-Warburton, M; Najle-Rahim, S; Oddsdottir, J; Pickard, AS; Ridley, C; Schrag, A; Sus, J; Xu, W1
Lezzi, P; Lezzi, T; Lupo, R; Vitale, E1
Baróti, B; Constantin, V; Forró, T; Frigy, A; Kelemen, K; Metz, J; Mihály, I; Orbán-Kis, K; Szász, JA; Szász, RM; Szatmári, S; Török, Á1
Liu, X; Ming, D; Moussian, B; Pang, M; Peng, R; Su, Y; Wang, P; Wang, Y; Zhu, Y1
Jog, M; Kumar, N1
Freeman, R; Goldstein, DS; Holmes, C; Kaufmann, H; Nardin, R; Saadia, D; Voustianiouk, A; Yahr, MD1

Reviews

2 review(s) available for carbidopa and Degenerative Diseases, Central Nervous System

ArticleYear
The Prephase Nursing in Levodopa Carbidopa Intestinal Gel Therapy.
    The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses, 2022, Oct-01, Volume: 54, Issue:5

    Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gels; Humans; Levodopa; Male; Neurodegenerative Diseases; Parkinson Disease; Quality of Life

2022
Molecular understanding of the translational models and the therapeutic potential natural products of Parkinson's disease.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 155

    Topics: Aged; Biological Products; Carbidopa; Cholinergic Antagonists; Dopamine; Dopamine Agonists; Humans; Levodopa; Monoamine Oxidase; Neurodegenerative Diseases; Parkinson Disease

2022

Trials

1 trial(s) available for carbidopa and Degenerative Diseases, Central Nervous System

ArticleYear
Norepinephrine precursor therapy in neurogenic orthostatic hypotension.
    Circulation, 2003, Aug-12, Volume: 108, Issue:6

    Topics: Administration, Oral; Aged; Antiparkinson Agents; Aromatic-L-Amino-Acid Decarboxylases; Blood Pressure; Carbidopa; Cross-Over Studies; Double-Blind Method; Droxidopa; Female; Hemodynamics; Humans; Hypotension, Orthostatic; Male; Middle Aged; Neurodegenerative Diseases; Norepinephrine; Posture; Single-Blind Method; Treatment Outcome

2003

Other Studies

4 other study(ies) available for carbidopa and Degenerative Diseases, Central Nervous System

ArticleYear
Spinocerebellar ataxia type 3: response to levodopa infusion in two cases.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2022, Volume: 43, Issue:5

    Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Gels; Humans; Infusions, Parenteral; Levodopa; Machado-Joseph Disease; Neurodegenerative Diseases; Parkinson Disease; Parkinsonian Disorders

2022
The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson's Disease in England.
    PharmacoEconomics, 2022, Volume: 40, Issue:5

    Topics: Antiparkinson Agents; Carbidopa; Cost-Benefit Analysis; Drug Combinations; Gels; Humans; Levodopa; Neurodegenerative Diseases; Parkinson Disease; Quality of Life

2022
Ten-year trends of the characteristics in patients with advanced Parkinson's disease at the time of intestinal gel therapy introduction
    Orvosi hetilap, 2022, Jul-24, Volume: 163, Issue:30

    Topics: Antiparkinson Agents; Carbidopa; Drug Combinations; Dyskinesias; Gels; Humans; Levodopa; Male; Neurodegenerative Diseases; Parkinson Disease; Retrospective Studies

2022
Fahr's Disease Presenting as Late-Onset Levodopa-Responsive Parkinsonism.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2017, Volume: 44, Issue:3

    Topics: Aged; Antiparkinson Agents; Basal Ganglia Diseases; Calcinosis; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Neurodegenerative Diseases

2017